🔗 Share this article

Acclaimed R&B singer D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our family has faded away for us in the present world,” his family confirmed. “After a prolonged and courageous battle with the disease, we are deeply saddened to announce that Michael D’Angelo Archer, recognized by his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his pioneering neo-soul sound and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The record reached No. 4 on the R&B charts, earned platinum status later that year, and received several award nominations.

However, it was his second album, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The record debuted at the top spot on both the R&B charts and the Billboard 200. He won two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the public consciousness. The intimate portrayal featured the artist, notably stripped down to his waist, performing directly into the camera.

D’Angelo retreated from the spotlight after putting out Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious vehicle accident that put him in grave health.

More than a decade later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the R&B chart and a award for Top R&B Record.

Again, in his own mysterious way, D’Angelo had limited public appearances in the subsequent period.

The musician was scheduled as a top act for the 2025 music event, but his performance was called off, due to an “unforeseen medical delay.”

Although information is limited about D’Angelo’s well-being in the months leading up to his death, he had apparently been hospitalized for an extended period and in palliative care for two weeks.

D’Angelo’s passing is a clear example of the harmful impact of pancreatic malignancy, one of the most deadly and least preventable types of the illness, on a gifted artist whose existence was ended too soon.

“We are grieved that he can only leave dear memories with his loved ones, but we are eternally grateful for the legacy of deeply emotional music he leaves behind,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy affects the digestive organ, a small organ that produces insulin and is vital in digestion, among other functions. The position and dimensions of the pancreas in the body make it more difficult to detect malignancy.

Even though this cancer makes up only approximately three percent of cancer diagnoses annually in the United States, it is responsible for seven percent of cancer deaths.

Almost seventy thousand individuals will be diagnosed with this condition and roughly 52,000 will succumb to the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and poor prognosis. We have limited and poor therapies, and a smaller window to make a meaningful impact on the lives of patients,” said a medical oncologist.

Since this disease seldom produces initial signs, it’s often identified only after the disease is advanced. Even when a individual has indicators they are often nonspecific and may be confused with a number of common illnesses.

“As of yet, there is no good way to detect pancreatic cancer in the early stages, except for paying attention to physical changes and consulting your doctor if there are unfamiliar symptoms,” said a medical director.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• weight loss
• yellowing of skin and eyes
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• nausea

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is most common in individuals in the 65 to 75 range. However, many cancers, such as this type, have become more common among younger people.

“This disease identified before the age of 50 is considered rare, yet alarmingly, doctors are beginning to see a rising count of younger individuals affected by this disease,” commented a expert.

Genetic Background Impacts Cancer Risk

Without effective screening tools for this malignancy, experts emphasized the significance of knowing your family’s cancer history. Certain risk factors, such as tobacco use and excess weight also have an influence in the development of pancreatic cancer.

African Americans have the greatest occurrence of pancreatic cancer in the United States and are most likely to be found to have untreatable disease.

“The initial action toward reducing one’s risk of this condition is understanding individual susceptibility. Individuals should examine their genetic background, hereditary factors, and medical conditions, such as diabetes, chronic pancreatitis, or obesity that may increase their susceptibility,” said a specialist.

Inherited genetic elements are associated with as much as 10% of all this malignancy cases. If someone in your household has had this disease, you may want to think about genetic testing.

“For people with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect initial alterations in the organ,” he clarified.

For those wishing to lower their chance, habit adjustments may make a difference. The most effective action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, stay away altogether.

Excessive alcohol consumption is linked to pancreatitis, a risk factor for this malignancy, so limiting or avoiding alcohol may help lower your chance.

Managing your body mass or losing weight may also help decrease your susceptibility. Individuals with excess weight are 20% more likely to get pancreatic cancer. Pancreatic cancer also is more frequent in those with blood sugar issues, and reducing weight can also lower the chance of type 2 diabetes.

Despite pancreatic cancer’s grim outlook, there is reason for optimism.

“We are doing better with therapies and newer combination chemotherapy. There are developing targeted therapies that already are making an impact,” said a specialist.

For many individuals, however, education about this uncommon but {dev